Value through Innovation26 May 2013
Corporate Profile

Page content

jump to main navigation jump to meta navigation

Taking the Initiative against Counterfeiting

Counterfeit medicines are a threat to the health and safety of patients around the world. Counterfeiting medical products is a serious crime that puts human lives at risk and undermines the credibility of health care systems. It also damages healthcare companies by associating them with sub-standard and dangerous products.

Counterfeit Medicines

  • Facts and Figures

    Facts and Figures

    The opening of markets created common economic areas and modern types of trade such as the globalisation of the pharmaceutical industry.

    read more
  • Dangers of Counterfeit Drugs

    Dangers of Counterfeit Drugs

    An individual who receives a counterfeit drug may risk a number of dangerous health consequences.

    read more
  • Global Cooperation

    Global Cooperation

    Co-ordinated national, regional and international strategies are essential.

    read more
  • Boehringer Ingelheim's Commitment

    Our Commitment

    Boehringer Ingelheim actively supports international institutions in their fight against counterfeits. We implemented measures.

    read more
  • What can the Patient do?

    What can the Patient do?

    It is very difficult to distinguish a counterfeit from the genuine product. Consumers can protect themselfs.

    read more
back to top

Anti-Counterfeiting Initiatives

Our Policy

Boehringer Ingelheim's policy for fighting against counterfeits, fakes and substandard drugs.

Download (PDF 66 KB)